Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery for Unprotected Left Main Coronary Artery Disease in the Drug-Eluting Stents Era-Reference-Cited by-同舟云学术

Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery for Unprotected Left Main Coronary Artery Disease in the Drug-Eluting Stents Era

Published:2013 Issue:2 Volume:77 Page:372-382
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Alam Mahboob¹,Huang Henry D.¹,Shahzad Saima A.²,Kar Biswajit³,Virani Salim S.¹³,Rogers Paul A.¹,Paniagua David¹³,Bozkurt Biykem¹³,Palacios Igor⁴,Kleiman Neal S.⁵⁶,Jneid Hani¹³

Affiliation:

1. Baylor College of Medicine

2. Al-Noor Specialist Hospital

3. Michael E. DeBakey VA Medical Center

4. Cardiac Unit, Massachusetts General Hospital and Harvard Medical School

5. Methodist DeBakey Heart and Vascular Center

6. Weill Cornell Medical College

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/77/2/77_CJ-12-0747/_pdf

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Coronary Heart Disease Patients with SYNTAX Score ≥33 and Euro Score ≥6: A Single-Center Retrospective Analysis;The Heart Surgery Forum;2023-12-27

2. Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis;Cureus;2023-11-05

3. Neurologic Complications of Cardiac and Pulmonary Disease;CONTINUUM: Lifelong Learning in Neurology;2023-06

4. Comparative Effectiveness of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention for Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Clinical Trials;Cureus;2022-09-23

5. Yangxinshi Tablet Improves Exercise Capacity for Patients with Coronary Heart Disease: Results from a Randomized, Double-Blind, Placebo-Controlled, and Multicenter Trial;Reviews in Cardiovascular Medicine;2022-07-21